SKIN — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-05-07

• SkinHealth Systems Inc. (the “Company” or “SkinHealth Systems”) is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions designed to help consumers achieve superior skin health and support the success of providers. Anchored by Hydrafacial, a leading an…

• •Market conditions, including increased competition and the interest rate environment, affecting the ability of potential customers to obtain credit on acceptable terms and longer sales cycles;

• •The imposition of tariffs and/or trade restrictions, due to geopolitical tensions or otherwise, may impact material costs and pricing;

• •Changes in applicable laws, regulations, regulatory interpretations, or enforcement policies in countries in which we operate;

• •Disruptions in transportation and other supply chain related constraints, such as labor strife in the transportation industry or geopolitical tensions; and

Text removed vs the prior filing · source: 10-Q · 2025-11-06

• The Beauty Health Company is a medtech meets beauty company that delivers skin health experiences that help consumers reinvent their relationship with their skin, bodies and self-confidence. The Company and its subsidiaries design, develop, manufacture, market, and sell esthetic technologies and pro…

• •The imposition of tariffs and/or trade restrictions may impact material costs and pricing;

• •Disruptions in transportation and other supply chain related constraints, such as labor strife in the transportation industry; and

• The Company evaluated its global distribution strategy to align its go-to-market strategy with in-market partner capabilities and market opportunity. During the second quarter of 2025, the Company transitioned sales in the China market to a distributor partner, and as a result, the Company has disco…

• Comparison of Three Months Ended September 30, 2025 to Three Months Ended September 30, 2024

Text added vs the prior filing · source: 10-Q · 2026-05-07

• There have been no changes in our internal control over financial reporting (as such term is defined in the Exchange Act) that occurred during the three months ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial repor…

Text removed vs the prior filing · source: 10-Q · 2025-11-06

• The Company, with oversight from our Audit Committee, has made progress on its remediation plan specific to the material weakness, with the completion of the following remediation activities as of September 30, 2025:

• •The Company appointed new individuals in key roles including the Chief Supply Chain and Operations Officer and other operational leadership roles;

• •Enhanced training and operational guidelines resulting in the successful completion of the Company’s annual physical inventory counts; and

• •Designed and implemented controls with regards to excess and obsolete inventory and inventory pricing and purchase arrangements.

• The Company has implemented the remediation steps detailed above; however, the Company is unable to conclude that these controls are operating effectively until the applicable controls operate for a sufficient period of time and are subject to testing to conclude that remediation has been achieved. …

Text added vs the prior filing · source: 10-Q · 2026-05-07

• On February 12, 2026, the director of the U.S.P.T.O. de-instituted and denied the second IPR challenging the ’287 Patent (IPR2025-00145). On April 20, 2026, the director denied Sinclair’s request for rehearing of that de-institution decision. The only IPR proceedings still pending against Hydrafacia…

• On May 6, 2024, Hydrafacial filed a complaint against Medicreations LLC (“Medicreations”) in the United States District Court for Nevada, Case Number 2:24-cv-00855 (the “Medicreations Case”), for patent infringement arising from Medicreations’ sale of hydrodermabrasion systems that Hydrafacial alleg…

• On July 24, 2024, Hydrafacial filed a complaint against Sinclair Pharma US, Inc (“Sinclair”), and its distributor Viora, Inc (“Viora”), in the United States District Court for the Central District of California, Case No. 2:24-cv-06250 (the “Sinclair Case”), for patent infringement arising from Sincl…

• On June 2, 2025, Plaintiff and fifteen other alleged purchasers of the Syndeo machines (“Plaintiffs”) filed an amended complaint (the “Amended Complaint”) asserting: (1) violations of N.Y. G.B.L., § 349 (Count IV), the state consumer protection statute; (2) violations of N.Y. G.B.L., § 350 (Count V)…

• On January 9, 2026, Class Action Plaintiffs filed a letter motion for leave to file a second amended complaint and for reconsideration of the Court’s dismissal of Plaintiffs’ claims for breach of express and implied contract and class-wide rescission based on fraudulent inducement (Count II). Class …

Text removed vs the prior filing · source: 10-Q · 2025-11-06

• On May 6, 2024, Hydrafacial filed a complaint against Medicreations LLC (“Medicreations”) in the United States District Court for Nevada, Case Number 2:24-cv-00855 (the “Medicreations Case”), for patent infringement arising from Medicreations’ sale of hydrodermabrasion systems that Hydrafacial alleg…

• On July 24, 2024, Hydrafacial filed a complaint against Sinclair Pharma US, Inc (“Sinclair”), and its distributor Viora, Inc (“Viora”), in the United States District Court for the Central District of California, Case No. 2:24-cv-06250 (the “Sinclair Case”), for patent infringement arising from Sincl…

• The Company believes that the claims asserted in the Customer Class Action have no merit and Class Action Defendants intend to vigorously defend them

• The Company believes that the claims asserted in the Consolidated Derivative Action have no merit and intends to vigorously defend them.

• On January 11, 2024, the Company was informed that the SEC is conducting a formal investigation of the Company related to, among other things, the allegations brought against the Company in the Securities Class Action lawsuit. The Company has subsequently received subpoenas from the SEC for the prod…

Text added vs the prior filing · source: 10-Q · 2026-05-07

• Our rebranding involves costs and may not be favorably received

• On April 22, 2026, we changed our name from “The Beauty Health Company” to “SkinHealth Systems Inc.” We have incurred costs as a result of the rebranding and the SkinHealth Systems brand name may not achieve or maintain the brand name recognition or status of our former BeautyHealth brand. Our corpo…

Text removed vs the prior filing · source: 10-Q · 2025-11-06

• The terms of our 2028 Notes contains certain restrictive covenants which may restrict our current and future operations.

• The 2028 Indenture governing the 2028 Notes contains certain restrictive covenants including, but not limited to, restricting our ability to raise additional capital through debt financing, certain transactions involving the assets of guarantors, limitations on certain transaction types, including b…